SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 300 filers reported holding SEATTLE GENETICS INC in Q4 2017. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $508,000 | -85.2% | 9,492 | -85.7% | 0.02% | -84.5% |
| Q2 2017 | $3,430,000 | +1170.4% | 66,301 | +1194.7% | 0.13% | +1072.7% |
| Q4 2016 | $270,000 | -82.9% | 5,121 | -89.6% | 0.01% | -79.2% |
| Q4 2014 | $1,575,000 | +187.9% | 49,017 | +233.3% | 0.05% | +231.2% |
| Q3 2014 | $547,000 | -56.7% | 14,706 | -55.4% | 0.02% | -52.9% |
| Q2 2014 | $1,263,000 | -60.7% | 33,009 | -59.1% | 0.03% | -64.2% |
| Q4 2013 | $3,217,000 | – | 80,641 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
| Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
| Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
| Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
| DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
| Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
| EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
| Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
| CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |